Banca Profilo S.p.A.
Overview
Banca Profilo S.p.A. is an Italian investment bank and financial services firm specializing in private banking, asset management, and corporate finance for institutional and private clients.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Enthera | Jan 2021 | Series A | Co-investor |
| Alia Therapeutics | Apr 2023 | Seed | Co-investor |
For institutional investors. Book with your work email.
Key People
Francesca Romana Sabatini
Head of Equity Research and Corporate Broking. Head of Investor Relations.
alberto brambilla
Portfolio Manager of Private Account
Alberto BRAMBILLA
portfolio manager
Carlo Castoldi
Senior Portfolio Manager
francesco figliomeni
Portfolio Manager
stefano bettarini
Associate Portfolio Manager
Stefano bettarini
Portfolio manager
Stefano Bettarini
portfolio manager
Barbara Baschera
COMMUNICATIONS & INVESTOR RELATIONS
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Banca Profilo S.p.A. based?
Banca Profilo S.p.A. is headquartered in Milan, Italy.
When was Banca Profilo S.p.A. founded?
Banca Profilo S.p.A. was founded in 1988.
How many portfolio companies does Banca Profilo S.p.A. have?
Banca Profilo S.p.A. has 4 portfolio companies in Caplight's dataset.
What are some companies in Banca Profilo S.p.A.'s portfolio?
Portfolio companies visible on Caplight include Enthera, Alia Therapeutics.
What was Banca Profilo S.p.A.'s most recent investment shown here?
Banca Profilo S.p.A.'s most recent investment in this portfolio sample was in Alia Therapeutics in 2023.
What sectors does Banca Profilo S.p.A. focus on?
Banca Profilo S.p.A. focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Consumer & Commerce, Real Estate & PropTech, Crypto & Web3.
What company stages does Banca Profilo S.p.A. focus on?
Banca Profilo S.p.A. typically invests at the Late stage.
What is Banca Profilo S.p.A.'s AUM?
Banca Profilo S.p.A.'s assets under management are estimated at over $6.5B.